Page 66 - Mployee Wellness Programs News Today

During a panel at MedCity News’ INVEST Digital Health conference, three executives representing a provider, a payer and a technology vendor shared their thoughts on how to heal the rocky relationship between hospitals and health plans. For instance, one leader encouraged payers and providers not to be afraid to give up some control, and another urged them to build comprehensive risk models.

The lack of proper healthcare infrastructure, human resources, equipment, and funding can reduce the quality of care in rural hospitals and clinics. It's crucial to improve the rural healthcare delivery models and provide quality care to the residents.

Season 4 launches with a focus on health equity and a conversation with Dr. Alisahah Jackson, system vice president of population health innovation and policy at CommonSpirit Health.

Femtech was the theme of the INVEST Digital Health Pitch Perfect contest in Dallas this week. Seven companies presented their approaches to addressing women's health.

Although the definition is evolving, truly personalized cancer care might be thought of as having four major pillars: interrogation of the cancer, predictive testing, inherited genes, and patient lifestyle, values and goals.

In a recent call for action, leading medical bodies agree that telehealth is integral to providing accessible and equitable mental health care for children.

Improving encounter processing and reporting can safeguard and maximize revenue and operating margins providing the financial resources for payers to continue providing members with quality, life-enhancing healthcare.

Women are in need of more menopause support through their employers, but many are reluctant to talk about it because of the stigma, said Alicia Jackson, CEO and founder of Evernow, during a panel discussion at HLTH.

Johnson & Johnson released research this month showing that its system for robotic-assisted bronchoscopy helped physicians achieve an over 15% improvement in overall diagnostic yield compared to traditional bronchoscopy. This could mean that fewer patients will have to “wait and see” while their cancer potentially gets worse.

Servier drug Tibsovo is now approved for treating advanced cases of myelodysplastic syndrome that have an IDH1 mutation. It’s the first approval of a targeted therapy for this type of cancer.